Molecular-engineering platform that builds CRISPR enzymes from the ground up and licenses them for in vivo gene editing.
Genetic-medicines platform that mines metagenomic sequence data to build a broad, proprietary gene-editing toolbox.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →